El hábito de fumar, un factor de riesgo cardiovascular modificable

1. Organización Mundial de la Salud. Estadísticas sanitarias mundiales [Internet]. 2010 [citado 15 Jul 2011]. Disponible en: www.who.int/entity/whosis/whostat/ES_WHS10_Full.pdf

2. Regueira G, Suárez-Lugo N, Jakimczuk S. Estrategias para la prevención del tabaco con perspectiva de género en América Latina. Salud Pública Mex. 2010;52(2):315-30.

3. Instituto del Corazón de Texas. Factores de riesgo cardiovascular [Internet]. 2011 [citado 15 Jul 2011]. Disponible en: http://www.texasheartinstitute.org/hic/topics_esp/hsmart/riskspan.cfm

4. D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care. The Framingham Heart Study. Circulation. 2008;117(6):743-53.

5. Aladro Miranda IF. Evaluación clínica, eléctrica y ecocardiográfica de pacientes sometidos a angioplastia coronaria con implantación de stent. [Trabajo de terminación de especialidad]. Hospital Universitario “Celestino Hernández Robau”. Villa Clara: UCM; 2007.

6. Piñón P, Kaski JC. Inflamación, aterosclerosis y riesgo cardiovascular: PAPP-A, Lp-PLA2 y cistatina C. ¿Nuevas aportaciones o información redundante? Rev Esp Cardiol. 2006;59:247-58.

7. Ross R. Atherosclerosis-An inflammatory disease. N Engl J Med. 1999;340(2):115-26.

8. Sitia S, Tomasoni L, Atzeni F, Ambrosio G, Cordiano C, Catapano A, et al. From endothelial dysfunction to atherosclerosis. Autoimmun Rev. 2010;9(12):830-4.

9. Rautou PE, Vion AC, Amabile N, Chironi G, Simon A, Tedgui A, et al. Microparticles, vascular function, and atherothrombosis. Circ Res. 2011;109(5):593-606.

10. Mannan H, Stevenson C, Peeters A, Walls H, McNeil J. Framingham risk prediction equations for incidence of cardiovascular disease using detailed measures for smoking. Heart Int. 2010;5:e11.49-57.

11. Muñón J, Egido J. Disfunción endotelial, inflamación y estatinas: nuevas evidencias. Rev Esp Cardiol. 2004;57(10):903-5.

12. Guarino F, Cantarella G, Caruso M, Russo C, Mancuso S, Arcidiacono G, et al. Endothelial activation and injury by cigarette smoke exposure. J Biol Regul Homeost Agents. 2011;25(2):259-68.

13. Nguyen AB, Rohatgi A, Garcia CK, Ayers CR, Das SR, Lakoski SG, et al. Interactions between smoking, pulmonary surfactant protein B, and atherosclerosis in the general population: the Dallas Heart Study. Arterioscler Thromb Vasc Biol. 2011;31(9):2136-43.

14. Balanescu S, Calmac L, Constantinescu D, Marinescu M, Onut R, Dorobantu M. Systemic inflammation and early atheroma formation: are they related? Maedica (Buchar). 2010;5(4):292-301.

15. Centers for Disease Control and Prevention (CDC). Current cigarette smoking prevalence among working adults--United States, 2004-2010. MMWR Morb Mortal Wkly Rep. 2011;60(38):1305-9.

16. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet. 2011;378(9799):1297-305.

17. Norhammar A, Malmberg K, Diderholm E, Lagerqvist B, Lindahl B, Rydén L, et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol. 2004;43(4):585-91.

18. Aguilar C, Vázquez C, Gamboa R, García N, Ríos JJ, Holguen R, et al. Obesity, diabetes, hypertension and tobacco consumption in an urban adult Mexican population. Arch Med Res. 2001;32(5):446-53.

19. Hochholzer W, Trenk D, Mega JL, Morath T, Stratz C, Valina CM, et al. Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy. Am Heart J. 2011;162(3):518-26.e5.

20. Singh RB, Fedacko J, Vargova V, Kumar A, Mohan V, Pella D, et al. Singh's verbal autopsy questionnaire for the assessment of causes of death, social autopsy, tobacco autopsy and dietary autopsy, based on medical records and interview. Acta Cardiol. 2011;66(4):471-81.

21. Pichon-Riviere A, Augustovski F, Bardach A, Colantonio L; Latinclen Tobacco Research Group. Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America. Value Health. 2011;14(5 Suppl 1):S51-9.

22. Villalbí JR, Castillo A, Cleries M, Saltó E, Sánchez E, Martínez R, et al; Barcelona Group. Estadísticas de alta hospitalaria del infarto agudo de miocardio: declive aparente con la extensión de espacios sin humo. Rev Esp Cardiol. 2009;62:812-5.